1. 1 Stein H, Foss HD, Dürkop H, Marafioti T, Delsol G, et al.: CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96:3681-3695, 2000
2. 2 Delsol G, Jaffe ES, Falini B, Gascoyne RD, Müller-Hermelink HK, et al.: Anaplastic large cell lymphoma (ALCL), ALK-positive. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al. (eds): World Health Organization Classification of Tumours, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, International Agency for Research on Cancer (IARC), pp.312-316, 2008
3. 3 Chiarle R, Voena C, Ambrogio C, Piva R, Inghirami G: The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer 8:11-23, 2008
4. 4 Trinei M, Lanfrancone L, Campo E, Pulford K, Mason DY, et al.: A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. Cancer Res 60:793-798, 2000
5. 5 Feldman AL, Vasmatzis G, Asmann YW, Davila J, Middha S, et al.: Novel TRAF1-ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma. Genes Chromosomes Cancer 52:1097-1102, 2013